The importance of social ties in sustaining medication adherence in resource-limited settings.
作者信息
Tsai Alexander C, Bangsberg David R
出版信息
J Gen Intern Med. 2011 Dec;26(12):1391-3. doi: 10.1007/s11606-011-1841-3.
Abstract
摘要
相似文献
1
The importance of social ties in sustaining medication adherence in resource-limited settings.
J Gen Intern Med. 2011 Dec;26(12):1391-3. doi: 10.1007/s11606-011-1841-3.
2
A systematic review of adherence to cardiovascular medications in resource-limited settings.
J Gen Intern Med. 2011 Dec;26(12):1479-91. doi: 10.1007/s11606-011-1825-3. Epub 2011 Aug 20.
3
Prevention of cardiovascular disease in low resource settings.
Eur J Cardiovasc Prev Rehabil. 2007 Oct;14(5):587-8. doi: 10.1097/HJR.0b013e3282f21534.
4
Medical devices and diagnostics for cardiovascular diseases in low-resource settings.
J Cardiovasc Transl Res. 2014 Nov;7(8):737-48. doi: 10.1007/s12265-014-9591-3. Epub 2014 Oct 8.
5
Cardiovascular disease in primary care: concordance and risk reduction.
Br J Gen Pract. 2012 Jun;62(599):284-5. doi: 10.3399/bjgp12X641663.
6
The preventive polypill--much promise, insufficient evidence.
N Engl J Med. 2007 Jan 18;356(3):212. doi: 10.1056/NEJMp068219.
7
Polypill and global cardiovascular health strategies.
Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):24-9. doi: 10.1053/j.semtcvs.2011.05.005.
8
What's new in PICU in resource limited settings?
Intensive Care Med. 2018 Apr;44(4):467-469. doi: 10.1007/s00134-017-4905-y. Epub 2017 Sep 14.
9
Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings.
J Clin Epidemiol. 2011 Dec;64(12):1451-62. doi: 10.1016/j.jclinepi.2011.02.001. Epub 2011 May 6.
10
Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries.
J Am Coll Cardiol. 2011 May 17;57(20):1980-7. doi: 10.1016/j.jacc.2010.12.029.
引用本文的文献
1
Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South Africa.
SSM Popul Health. 2024 Jan 1;25:101593. doi: 10.1016/j.ssmph.2023.101593. eCollection 2024 Mar.
2
Socio-demographic, clinical and service use determinants associated with HIV related stigma among people living with HIV/AIDS: a systematic review and meta-analysis.
BMC Health Serv Res. 2021 Sep 22;21(1):1004. doi: 10.1186/s12913-021-06980-6.
3
Medication Adherence Among Elderly Patients with High Blood Pressure in Gweru, Zimbabwe.
J Public Health Afr. 2014 Apr 29;5(1):304. doi: 10.4081/jphia.2014.304. eCollection 2014 Feb 4.
4
Understanding Patterns of Social Support and Their Relationship to an ART Adherence Intervention Among Adults in Rural Southwestern Uganda.
AIDS Behav. 2017 Feb;21(2):428-440. doi: 10.1007/s10461-016-1559-7.
5
Explaining antiretroviral therapy adherence success among HIV-infected children in rural Uganda: a qualitative study.
AIDS Behav. 2015 Apr;19(4):584-93. doi: 10.1007/s10461-014-0924-7.
6
Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.
AIDS Behav. 2015 Apr;19(4):704-14. doi: 10.1007/s10461-014-0920-y.
7
Food insecurity is associated with increased risk of non-adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo: a cross-sectional study.
PLoS One. 2014 Jan 15;9(1):e85327. doi: 10.1371/journal.pone.0085327. eCollection 2014.
8
Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis.
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640. doi: 10.7448/IAS.16.3.18640.
9
Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda.
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):317-21. doi: 10.1097/QAI.0b013e3182800daf.
10
A typology of structural approaches to HIV prevention: a commentary on Roberts and Matthews.
Soc Sci Med. 2012 Nov;75(9):1562-7; discussion 1568-71. doi: 10.1016/j.socscimed.2012.06.033. Epub 2012 Jul 31.
本文引用的文献
1
A systematic review of adherence to cardiovascular medications in resource-limited settings.
J Gen Intern Med. 2011 Dec;26(12):1479-91. doi: 10.1007/s11606-011-1825-3. Epub 2011 Aug 20.
2
Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases.
Glob Public Health. 2011;6(3):247-56. doi: 10.1080/17441692.2011.552068.
3
Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research.
AIDS. 2011 Jan 28;25(3):279-90. doi: 10.1097/QAD.0b013e328340feb0.
4
The transition to living with HIV as a chronic condition in rural Uganda: working to create order and control when on antiretroviral therapy.
Soc Sci Med. 2010 Feb;70(3):375-382. doi: 10.1016/j.socscimed.2009.10.039. Epub 2009 Nov 14.
5
Achieving the health Millennium Development Goals for South Africa: challenges and priorities.
Lancet. 2009 Sep 19;374(9694):1023-1031. doi: 10.1016/S0140-6736(09)61122-3. Epub 2009 Aug 24.
6
Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):280-9. doi: 10.1097/QAI.0b013e3181ab6eab.
7
Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time.
AIDS Behav. 2009 Jun;13 Suppl 1:82-91. doi: 10.1007/s10461-009-9546-x. Epub 2009 Mar 20.
8
Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study.
AIDS Behav. 2010 Aug;14(4):778-84. doi: 10.1007/s10461-009-9533-2. Epub 2009 Mar 13.
9
Explaining adherence success in sub-Saharan Africa: an ethnographic study.
PLoS Med. 2009 Jan 27;6(1):e11. doi: 10.1371/journal.pmed.1000011.
10
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care.
Lancet. 2008 Sep 13;372(9642):940-9. doi: 10.1016/S0140-6736(08)61404-X.
Zotero 插件